consumer healthcare

Sanofi in Talks to Sell Stake in Opella to CD&R

Sanofi has entered into talks with Clayton Dubilier & Rice (CD&R), a US-based investment company, about the potential sale of a 50% controlling stake in the French drugmaker‘s consumer healthcare business, Opella.

Ipsen in Talks to Sell Consumer Healthcare to Mayoly Spindler

French pharma Ipsen has entered into exclusive negotiations for the sale of its global consumer healthcare business to compatriot firm Mayoly Spindler. The move, said Ipsen, is a major step forward in its strategy to sharpen its focus on specialty care.

GSK-Pfizer Complete Consumer Health JV

Pfizer Mulls Sale of Consumer Health Unit

Sanofi to Sell Five OTC Products to Ipsen

Walmsley Named New CEO of GSK

Bayer in Push to Lift US Profile

Sanofi and Boehringer Ingelheim Agree Asset Swap

Nestle Boosts Skincare Business With Valeant Deal

New Valeant Bid Values Allergan at $49.44 Billion

Bayer to Pay $14.2 Billion for U.S. Merck’s Consumer Business

Pfizer Ups Offer for AstraZeneca to $106 Billion

Merck Consumer Unit Said to be Worth $14 Billion for Bayer

Pfizer Chases AstraZeneca for Potential $100 billion Deal

Zimmer to Buy Biomet for $13.35 Billion

Bayer and Reckitt Said Finalists for Merck & Co. Consumer Arm

Bayer, Novartis said to Eye Merck & Co consumer health unit

Bayer’s Contraceptive Patch Registered in EU

India Regulators Pull J&J Plant License on Baby Powder Concerns

GSK Spends $900 Million to Lift Stake in India Consumer Arm

Consumer Healthcare

Mobilizing for Action in Consumer Healthcare

GSK to Raise India Unit Stake in $940 Million Deal